Obchod SURF

Surface Oncology Inc

-

00:00:00

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited to develop, manufacture, and commercialize antibodies that targets SRF813; and license agreement with Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Více informací...

SURF
Obchodní specifikace

Číslice

3

Bod

0.001

Spread

floating

Velikost smlouvy

1

Objem min.

1

Maximální objem

10,000

Krok svazku

1

Výměna dlouhých (bodů)

-0.310

Swap Short (body)

-0.180
K dispozici na
MT5, TV, cTrader
Poslední aktualizace v 13 listopadu, 20:08 GMT+3
*Zdroj dat: MT5 Server Prime Account Pricing

SURF
Ekonomický kalendář

Nebyly nalezeny žádné údaje

1D Změna

-

Proč BlackBull Markets?

26k+

Obchodovatelná aktiva

1:500

Pákový efekt až do

Regulované stránky

Víceregulátorové

24/7

Zákaznická podpora

$0

Žádný minimální vklad

Kalkulačka marže

Calculation Results

Current Price

0.00

Required Margin

Converted Currency

Required Margin

Account Base Currency

Kalkulačka zisku/ztráty

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

Kalkulačka swapů

Calculation Results

0.00

Obchodní příležitosti

Nebyly nalezeny žádné údaje
Join Now